iECURE_Logo

iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506

ECUR-506 is a gene editing-based investigational therapy for the treatment of Ornithine Transcarbamylase (OTC) deficiency PHILADELPHIA--(BUSINESS WIRE)--iECURE, Inc., a gene...

Hollow_Fiber_Membranes_for_Dehydration

Asahi Kasei develops novel membrane system to dehydrate organic solvents without heat or pressure – Contributing to process optimization in the pharmaceutical industry

DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)--Asahi Kasei has developed a novel membrane system for dehydrating organic solvents for pharmaceutical applications without...